Imperial College London

Jiri Pavlu

Faculty of MedicineDepartment of Immunology and Inflammation

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

+44 (0)20 3313 8117j.pavlu Website

 
 
//

Location

 

Leuka Building R2.20Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Craddock:2017,
author = {Craddock, C and Tholouli, E and Vicente, SM and Gbandi, E and Houlton, AE and Drummond, MW and Pavlu, J and Vyas, P},
publisher = {AMER SOC HEMATOLOGY},
title = {Safety and Clinical Activity of Combined Romidepsin and Azacitidine Therapy in High Risk Acute Myeloid Leukemia: Preliminary Results of the Romaza Trial},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432419406214&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Craddock,C
AU - Tholouli,E
AU - Vicente,SM
AU - Gbandi,E
AU - Houlton,AE
AU - Drummond,MW
AU - Pavlu,J
AU - Vyas,P
PB - AMER SOC HEMATOLOGY
PY - 2017///
SN - 0006-4971
TI - Safety and Clinical Activity of Combined Romidepsin and Azacitidine Therapy in High Risk Acute Myeloid Leukemia: Preliminary Results of the Romaza Trial
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432419406214&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -